0

Journal Articles

in Sickle Cell Disease/Thalassemias
 1-20 of 32 Articles
Research Letters |  March 28, 2012 FREE
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension
Alem Mehari, MD; Mark T. Gladwin, MD; Xin Tian, PhD; et al.
JAMA. 2012;307(12):1254-1256. doi:10.1001/jama.2012.358.
Preliminary Communication |  March 14, 2012 FREE
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung, MD, PhD; Jinghui Zhang, PhD; Charles Lu, PhD; et al.
JAMA. 2012;307(10):1062-1071. doi:10.1001/jama.2012.228.
INCLUDES: , Supplemental Content
Editorial |  January 04, 2012
The Debut of Viewpoints and Other New Developments at JAMA
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2012;307(1):90-91. doi:10.1001/jama.2011.1958.
Health Agencies Update |  November 23, 2011
Controversial Chelator Approved
Bridget M. Kuehn
JAMA. 2011;306(20):2207. doi:10.1001/jama.2011.1699.
Original Contribution |  March 02, 2011 FREE
Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis:  A Randomized Controlled Trial
Mark T. Gladwin, MD; Gregory J. Kato, MD; Debra Weiner, MD, PhD; et al.
JAMA. 2011;305(9):893-902. doi:10.1001/jama.2011.235.
INCLUDES: , Supplemental Content
Medical News & Perspectives |  January 19, 2011
Advances Reshaping Sickle Cell Therapy
M. J. Friedrich
JAMA. 2011;305(3):239-242. doi:10.1001/jama.2010.1929.
Health Agencies Update |  July 28, 2010
Sickle Cell Trial Halted
Bridget M. Kuehn
JAMA. 2010;304(4):398. doi:10.1001/jama.2010.968.
Editorial |  May 12, 2010
Neurocognitive Complications of Sickle Cell Anemia in Adults
Samir K. Ballas, MD
JAMA. 2010;303(18):1862-1863. doi:10.1001/jama.2010.610.
Original Contribution |  May 12, 2010 FREE
Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia
Elliott P. Vichinsky, MD; Lynne D. Neumayr, MD; Jeffrey I. Gold, PhD; et al.
JAMA. 2010;303(18):1823-1831. doi:10.1001/jama.2010.562.
INCLUDES: , Supplemental Content
Original Contribution |  April 07, 2010 FREE
Acute Care Utilization and Rehospitalizations for Sickle Cell Disease
David C. Brousseau, MD, MS; Pamela L. Owens, PhD; Andrew L. Mosso, MS; et al.
JAMA. 2010;303(13):1288-1294. doi:10.1001/jama.2010.378.
INCLUDES: , Supplemental Content
The World in Medicine |  October 21, 2009
Reducing Sickle Cell Deaths
Joan Stephenson, PhD
JAMA. 2009;302(15):1640. doi:10.1001/jama.2009.1528.
Medical News and Perspectives |  January 30, 2008
Strides Made in Red Blood Cell Disorders, but Substantial Barriers to Care Remain
JAMA. 2008;299(4):395-396. doi:10.1001/jama.2008.3.
Original Contribution |  July 19, 2006 FREE
N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Roberto F. Machado, MD; Anastasia Anthi, MD; Martin H. Steinberg, MD; et al.
JAMA. 2006;296(3):310-318. doi:10.1001/jama.296.3.310.
Lab, Field, and Clinic |  March 01, 2006
Yuet Wai Kan, MD
JAMA. 2006;295(9):991. doi:10.1001/jama.295.9.991.
Lab, Field, and Clinic |  October 05, 2005
Robert Langer, ScD—Engineering Medicine
JAMA. 2005;294(13):1609-1610. doi:10.1001/jama.294.13.1609.
Original Contribution |  July 06, 2005 FREE
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
Claudia R. Morris, MD; Gregory J. Kato, MD; Mirjana Poljakovic, PhD; et al.
JAMA. 2005;294(1):81-90. doi:10.1001/jama.294.1.81.
Clinical Review |  April 06, 2005 FREE
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin:  A Novel Mechanism of Human Disease
Russell P. Rother, PhD; Leonard Bell, MD; Peter Hillmen, MB, PhD; et al.
JAMA. 2005;293(13):1653-1662. doi:10.1001/jama.293.13.1653.
INCLUDES: CME
Preliminary Communication |  February 16, 2005 FREE
Detection of Paternally Inherited Fetal Point Mutations for β-Thalassemia Using Size-Fractionated Cell-Free DNA in Maternal Plasma
Ying Li, PhD; Edoardo Di Naro, MD; Angeloantonio Vitucci, MD; et al.
JAMA. 2005;293(7):843-849. doi:10.1001/jama.293.7.843.
The World inMedicine |  February 16, 2005
Culturing Blood
JAMA. 2005;293(7):790. doi:10.1001/jama.293.7.790-c.
Original Contribution |  August 27, 2003 FREE
Provision of Pneumococcal Prophylaxis for Publicly Insured Children With Sickle Cell Disease
Colin M. Sox, MD; William O. Cooper, MD, MPH; Thomas D. Koepsell, MD, MPH; et al.
JAMA. 2003;290(8):1057-1061. doi:10.1001/jama.290.8.1057.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  Jan 2013
Acute Silent Cerebral Ischemic Events in Children With Sickle Cell Anemia
Charles T. Quinn, MD, MS; Robert C. McKinstry, MD, PhD; Michael M. Dowling, MD, PhD; et al.
JAMA Surgery
Special Feature  |  May 2012
Image of the Month—Quiz Case
Megan Steigelman, MD; Matthew Chauviere, MD
JAMA Dermatology
Correspondence  |  Apr 2012
Topical Psoralen Plus UV-A Therapy for Tyrosine Kinase Inhibitor–Induced Hand-Foot Syndrome
JAMA Dermatology
Observation  |  Dec 2011
Capecitabine-Induced Hand-Foot Syndrome Complicated by Pseudomonal Superinfection Resulting in Bacterial Sepsis and Death:  Case Report and Review of the Literature
Fridolin J. Hoesly, MD; Sarah G. Baker, MD; Nilanthi D. Gunawardane, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems